Neogenomics Inc’s filing revealed that its Director TETRAULT LYNN A. acquired Company’s shares for reported $56974.0 on May 09 ’25. In the deal valued at $8.14 per share,7,000 shares were bought. As a result of this transaction, TETRAULT LYNN A. now holds 7,000 shares worth roughly $59570.0.
Then, KANOVSKY STEPHEN M bought 4,000 shares, generating $31,124 in total proceeds. Upon buying the shares at $7.78, the Director now owns 40,090 shares.
Before that, Zook Anthony P. bought 18,900 shares. Neogenomics Inc shares valued at $148,919 were divested by the Chief Executive Officer at a price of $7.88 per share. As a result of the transaction, Zook Anthony P. now holds 18,900 shares, worth roughly $0.16 million.
Leerink Partners downgraded its Neogenomics Inc [NEO] rating to a Market perform from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who decreased its forecast for the stock in mid January from “a Buy” to “a Hold”. Jefferies began covering NEO with “Buy” recommendation on December 10, 2024.
Price Performance Review of NEO
On Monday, Neogenomics Inc [NASDAQ:NEO] saw its stock jump 5.71% to $8.51. Over the last five days, the stock has gained 8.55%. Neogenomics Inc shares have fallen nearly -48.36% since the year began. Nevertheless, the stocks have fallen -43.75% over the past one year. While a 52-week high of $19.11 was reached on 01/08/25, a 52-week low of $6.08 was recorded on 04/30/25. SMA at 50 days reached $9.23, while 200 days put it at $13.77.
Levels Of Support And Resistance For NEO Stock
The 24-hour chart illustrates a support level at 8.26, which if violated will result in even more drops to 8.02. On the upside, there is a resistance level at 8.72. A further resistance level may holdings at 8.94. The Relative Strength Index (RSI) on the 14-day chart is 48.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.08, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 45.15%. Stochastics %K at 48.53% indicates the stock is a holding.
The most recent change occurred on December 29, 2023 when BTIG Research resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $21.
